Capital Research Global Investors
STJ

Capital Research Global Investors’s St Jude Medical STJ Stock Holding History

Capital Research Global Investors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,179,788
Closed -$335M – 455
2016
Q4 		$335M Sell
4,179,788
-593,142
-12% -$47.1M 0.11% 176
2016
Q3 		$381M Buy
4,772,930
+2,376,000
+99% +$192M 0.13% 165
2016
Q2 		$187M Sell
2,396,930
-19,989,217
-89% -$1.43B 0.06% 224
2016
Q1 		$1.23B Sell
22,386,147
-4,087,453
-15% -$223M 0.42% 66
2015
Q4 		$1.64B Sell
26,473,600
-4,962,296
-16% -$313M 0.56% 47
2015
Q3 		$1.98B Sell
31,435,896
-3,274,104
-9% -$234M 0.71% 37
2015
Q2 		$2.54B Hold
34,710,000
– – 0.83% 28
2015
Q1 		$2.27B Buy
34,710,000
+1,599,954
+5% +$106M 0.78% 30
2014
Q4 		$2.15B Buy
33,110,046
+2,807,875
+9% +$181M 0.73% 30
2014
Q3 		$1.82B Buy
30,302,171
+393,000
+1% +$25.7M 0.63% 37
2014
Q2 		$2.07B Buy
29,909,171
+5,856,481
+24% +$380M 0.72% 32
2014
Q1 		$1.57B Sell
24,052,690
-7,061,526
-23% -$460M 0.57% 50
2013
Q4 		$1.93B Sell
31,114,216
-2,815,100
-8% -$163M 0.71% 36
2013
Q3 		$1.82B Buy
33,929,316
+64,700
+0.2% +$3.33M 0.72% 35
2013
Q2 		$1.55B Buy
+33,864,616
New +$1.47B 0.66% 39

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Capital Research Global Investors's STJ Position: Q1 2017 in Review

Capital Research Global Investors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,179,788 shares — an estimated $335M sold.

Capital Research Global Investors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $2.54B in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Capital Research Global Investors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Capital Research Global Investors sold 4,179,788 St Jude Medical shares in Q1 2017, an estimated $335M.
  • Capital Research Global Investors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Capital Research Global Investors's St Jude Medical position peaked at $2.54B in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Capital Research Global Investors's 13F filing for Q1 2017, filed 15 May 2017.